Real-time enrollment status for this platinum-resistant ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:37 PM UTC
| NCT Number | NCT06515613 |
| Recruiting Status | Recruiting |
| Condition | Platinum-resistant Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 156 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Context Therapeutics Inc. |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 12, 2026: Clinical trial NCT06515613 is currently recruiting participants. This phase1 study for platinum-resistant ovarian cancer is actively seeking new participants at 14 locations across the United States. The study is sponsored by Context Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06515613 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06515613 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.